References
- 1MorganJCSethiKDDrug-induced tremorsLancet Neurol20054866876doi: 10.1016/S1474-4422(05)70250-716297844
- 2SethiKDZamriniEYAsymmetry in clinical features of drug-induced parkinsonismJ Neuropsychiatry Clin Neurosci199026466doi: 10.1176/jnp.2.1.641983774
- 3AydFA survey of drug-induced extrapyramidal reactionsJAMA196117510541060doi: 10.1001/jama.1961.0304012001600413685365
- 4SethiKDPatelBMeadorKJMetoclopramide-induced parkinsonismSouth Med J19898215811582doi: 10.1097/00007611-198912000-000332595431
- 5ShuaibUARajputAHRobinsonCARajputANeuroleptic-induced Parkinsonism: clinicopathological studyMov Disord201631360365doi: 10.1002/mds.2646726660063
- 6AthaudaDBatleyREllisCClinically silent idiopathic Parkinson’s disease unmasked by valproate use: a brief reportAging Clin Exp Res201527387390doi: 10.1007/s40520-014-0278-z25365950
- 7FactorSALithium-induced movement disordersSethiKDeditorDrug-induced movement disordersNew YorkMarcel Dekker2004209231
- 8GelenbergAJJeffersonJWLithium tremorJ Clin Psychiatry1995562832877615481
- 9BaekJHKinrysGNierenbergAALithium tremor revisited: pathophysiology and treatmentActa Psychiatr Scand20141291723doi: 10.1111/acps.1217123834617
- 10RaethjenJLemkeMRLindermanMWenzelburgerRKrackPDeuschlGAmitriptyline enhances the central component of physiological tremorJ Neurol Neurosurg Psychiatry2001707882doi: 10.1136/jnnp.70.1.7811118252
- 11SmithWTGlaudinVPanagidesJGilvaryEMirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorderPsychopharmacol Bull1990261911962236455
- 12ChouinardGA double-blind controlled clinical trial of fluoxetine and amitriptyline in the treatment of outpatients with major depressive disorderJ Clin Psychiatry1985463237
- 13FruensgaardKHansenCEKorsgaardSNymgaardKVaagUHAmoxapine versus amitriptyline in endogenous depression: a double-blind studyActa Psychiatr Scand197959502508doi: 10.1111/j.1600-0447.1979.tb00249.x380269
- 14VestergaardPPoulstrupIShouMProspective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaintsActa Psychiatr Scand198878434441doi: 10.1111/j.1600-0447.1988.tb06363.x3227963
- 15RinnerthalerMLuefGMuellerJSeppiKWisselJTrinkaEet alComputerized tremor analysis of valproate-induced tremor: a comparative study of controlled-release versus conventional valproateEpilepsia200546320323doi: 10.1111/j.0013-9580.2005.36204.x15679514
- 16LangoneASteinbergSMGedalyRChanLKShahTSethiKDet alSwitching STudy of Kidney TRansplant PAtients with Tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b studyClin Transplant201529796805doi: 10.1111/ctr.1258126113208
- 17HessCWPullmanSLTremor: clinical phenomenology and assessment techniquesTremor Other Hyperkinet Mov20122doi: 10.7916/D8WM1C41
- 18DeuschlGRaethjenJLindemannMKrackPThe pathophysiology of tremorMuscle Nerve200124716735doi: 10.1002/mus.106311360255
- 19CharnessMEMoradyFScheinmanMMFrequent neurologic toxicity associated with amiodarone therapyNeurology198434669671doi: 10.1212/WNL.34.5.6696538658
- 20CoulterDMEdwardsIRSavageRLSurvey of neurological problems with amiodarone in the New Zealand Intensive Medicines Monitoring ProgrammeNZ Med J199010398100
- 21MoradyFScheinmanMMHessDSAmiodarone in the management of patients with ventricular tachycardia and ventricular fibrillationPacing Clin Electrophysiol19836609615doi: 10.1111/j.1540-8159.1983.tb05302.x6191299
- 22HarrisLMcKennaWJRowlandEKriklerDMSide effects and possible contraindications of amiodarone useAm Heart J1983106916923doi: 10.1016/0002-8703(83)90016-96613838
- 23WernerEGOlanowCWParkinsonism and amiodarone therapyAnn Neurol198925630632doi: 10.1002/ana.4102506182742365
- 24BrienJFJimmoSBrennanFJFordSEArmstrongPWDistribution of amiodarone and its metabolite, desethylamiodarone, in human tissuesCan J Physiol Pharmacol198765360364doi: 10.1139/y87-0623580958
- 25OrrCFAhlskogJEFrequency, characteristics, and risk factors for amiodarone neurotoxicityArch Neurol200966865869doi: 10.1001/archneurol.2009.9619597088
- 26WatanabeSYokoyamaSKuboSIwaiHKuyamaCA double-blind controlled study of clinical efficacy of maprotiline and amitriptyline in depressionFolia Psychiatr Neurol Jpn197832131doi: 10.1111/j.1440-1819.1978.tb02776.x350736
- 27BharuchaKJSethiKDMovement disorders induced by selective serotonin reuptake inhibitors and other antidepressantsSethiKDeditorDrug-induced movement disordersNew YorkMarcel Dekker2004233257
- 28EdwardsJGAndersonISystematic review and guide to selection of selective serotonin reuptake inhibitorsDrugs199957507533doi: 10.2165/00003495-199957040-0000510235690
- 29Serrano-DueñasMFluoxetine-induced tremor: clinical features in 21 patientsParkinsonism Relat Disord20028325327doi: 10.1016/S1353-8020(01)00043-815177061
- 30CeravoloRSalvettiSPicciniPLucettiCGambacciniGBonuccelliUdoi: 10.1002/1531-8257(199905)14:3<468::AID-MDS1013>3.0.CO;2-M
- 31ArshaduddinMAl KadasahSBiaryNAl DeebSAl MoutaeryKTariqMCitalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in ratsBehav Brain Res20041531520doi: 10.1016/j.bbr.2003.10.03515219702
- 32
- 33LejoyeuxMAdesJAntidepressant discontinuation: a review of the literatureJ Clin Psychiatry199758(Suppl. 7)1115
- 34GoodwinFKJamisonKRMedication complianceGoodwinFKJamisonKRManic-depressive illnessNew YorkOxford University Press1990746762
- 35VestergaardPAmidsenAShouMClinically significant side effects of lithium treatment. A survey of 237 patients in long-term treatmentActa Psychiatr Scand198062193200doi: 10.1111/j.1600-0447.1980.tb00607.x7457166
- 36HenryCLithium side-effects and predictors of hypothyroidism in patients with bipolar disorder: sex differencesJ Psychiatry Neurosci20022710410711944505
- 37BechPThomsenJPrytzSVendsborgPBZilstorffKRafaelsenOJThe profile and severity of lithium-induced side effects in mentally healthy subjectsNeuropsychobiology19795160166doi: 10.1159/000117678372839
- 38ZaninelliRBauerMJobertMMuller-OerlinghausenBChanges in quantitatively assessed tremor during treatment of major depression with lithium augmented by paroxetine and amitriptylineJ Clin Psychopharmacol20012119098doi: 10.1097/00004714-200104000-0001111270916
- 39HolroydSSmithDDisabling parkinsonism due to lithium: a case reportJ Geriatr Psychiatry Neurol19958118119doi: 10.1177/0891988795008002087794475
- 40LeiPAytonSAppukuttanATMoonSDuceJAVolitakisIet alLithium suppression of tau induces brain iron accumulation and neurodegenerationMol Psychiatry22396406doi: 10.1038/mp.2016.96
- 41MorganJCHarrisonMBAntiepilepticsFactorSALangAEWeinerWJDrug-induced movement disorders2nd editionBostonBlackwell publishing2005408429
- 42KellettMWChadwickDWAntiepileptic drug-induced movement disordersSethiKDeditorDrug-induced movement disordersNew YorkMarcel Dekker2004309356
- 43HymanNMDennisPDSinclairKGTremor due to sodium valproateNeurology19792911771180doi: 10.1212/WNL.29.8.1177379690
- 44KarasBJWilderBJHammondEJBaumanAWValproate tremorsNeurology198232428432doi: 10.1212/WNL.32.4.4286801541
- 45MehndirattaMMSatyawaniMGuptaSKhwajaGAClinical and surface EMG characteristics of valproate induced tremorsElectromyogr Clin Neurophysiol20054517718215981690
- 46KarasBJWilderBJHammondEJBaumanAWTreatment of valproate tremorsNeurology19833313801382doi: 10.1212/WNL.33.10.13806412157
- 47LancmanMEAsconapeJJWalkerFAcetazolamide appears effective in the management of valproate-induced tremorMov Disord19949369doi: 10.1002/mds.870090321
- 48SilverMFactorSAValproic acid-induced parkinsonism: levodopa responsiveness with dyskinesiaParkinsonism Relat Disord201319758760doi: 10.1016/j.parkreldis.2013.03.01623632325
- 49VamosECsatiAVecseiLKlivenyiPEffects of valproate on the dopaminergic system in miceNeurol Res200931217219doi: 10.1179/174313208X34609918768113
- 50CazzolaMPageCPCalzettaLMateraMGPharmacology and therapeutics of bronchodilatorsPharmacol Rev201264450504doi: 10.1124/pr.111.00458022611179
- 51FoleyTHMarsdenCDOwenDAEvidence for a direct peripheral effect of adrenaline on physiological tremor in manJ Physiol196718965P66P
- 52AhrensRCSkeletal muscle tremor and the influence of adrenergic drugsJ Asthma1990271120doi: 10.3109/027709090090732891968452
- 53YoungRRGrowdonJHShahaniBTBeta-adrenergic mechanisms in action tremorN Engl J Med1975293950953doi: 10.1056/NEJM1975110629319021178003
- 54AbilaBWilsonJFMarshallRWRichensAThe tremorolytic action of beta-adrenoceptor blockers in essential, physiological and isoprenaline-induced tremor is mediated by beta-adrenoceptors located in a deep peripheral compartmentBr J Clin Pharmacol198520369376doi: 10.1111/j.1365-2125.1985.tb05079.x2866785
- 55BakerMABakerSNBeta-adrenergic modulation of tremor and corticomuscular coherence in humansPLoS One20127e49088doi: 10.1371/journal.pone.004908823185297
- 56ChangAFoxSHPsychosis in Parkinson’s disease: epidemiology, pathophysiology, and managementDrugs20167610931118doi: 10.1007/s40265-016-0600-527312429
- 57CagnanHLittleSFoltynieTLimousinPZrinzoLHarizMet alThe nature of tremor circuits in parkinsonian and essential tremorBrain201413732233234doi: 10.1093/brain/awu25025200741
- 58BegaDGonzalez-LatapiPZadikoffCSpiesWSimuniTIs there a role for DAT-SPECT imaging in a specialty movement disorders practice?Neurodegener Dis2015158186doi: 10.1159/00037011625592727
- 59
- 60RodriguesBPatilPGChouKLThalamic deep brain stimulation for drug-induced tremorParkinsonism Relat Disord20152113691370doi: 10.1016/j.parkreldis.2015.08.03326350120
- 61PaulFMüllerJChristeWSteinmüllerTPoeweWWisselJPostural hand tremor before and following liver transplantation and immunosuppression with cyclosporine or tacrolimus in patients without clinical signs of hepatic encephalopathyClin Transplant200418429433doi: 10.1111/j.1399-0012.2004.00184.x15233821
- 62GijtenbeekJMvan den BentMJVechtCJCyclosporine neurotoxicity: a reviewJ Neurol1999246339346doi: 10.1007/s00415005036010399863
- 63
- 64MunhozRPTeiveHAGerminianiFMGerytchJCSáDSBittencourtMAet alMovement disorders secondary to long-term treatment with cyclosporine AArq Neuropsiquiatr200563592596doi: 10.1590/S0004-282X200500040000716172706
- 65SamiiASlimpJCHoganPJ
3rd GoodkinRDeep brain stimulation in a patient on immunosuppressive therapy after renal transplantParkinsonism Relat Disord200511259260doi: 10.1016/j.parkreldis.2004.11.00215878589 - 66RosendalFBjarkamCRLarsenMHansenHEMadsenMSørensenJCet alDoes chronic low-dose treatment with cyclosporine influence the brain? A histopathological study in pigsTransplant Proc20053733053308doi: 10.1016/j.transproceed.2005.09.01516298581
- 67WijdicksEFWiesnerRHDahlkeLJKromRAFK 506-induced neurotoxicity in liver transplantationAnn Neurol199435498501doi: 10.1002/ana.4103504227512320
- 68UemotoSTanakaKHondaKYukihikoTKaoruSHironoriKet alExperience with FK506 in living-related liver transplantationTransplantation199355288292doi: 10.1097/00007890-199302000-000117679528
- 69YocumDEFurstDEBensenWGBurchFXBortonMAMengle-GawLJet alSafety of tacrolimus in patients with rheumatoid arthritis: long-term experienceRheumatology200443992999doi: 10.1093/rheumatology/keh15515014199
- 70JennerPAn overview of adenosine A2A receptor antagonists in Parkinson’s diseaseInt Rev Neurobiol20141197186doi: 10.1016/B978-0-12-801022-8.00003-925175961
- 71KulisevskyJBarbanojMGironellAAntonijoanRCasasMPascual-SedanoBA double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson's diseaseClin Neuropharmacol2002252531doi: 10.1097/00002826-200201000-0000511852293
- 72BussDCMarshallRWMilliganNMcQueenICompstonDARoutledgePAThe effect of intravenous aminophylline on essential tremorBr J Clin Pharmacol199743119121doi: 10.1111/j.1365-2125.1997.tb00149.x9056064
- 73BussDCPhillipsDILittleyMDMarshallRWRoutledgePALazarusJHThe effect of theophylline on thyrotoxic tremorBr J Clin Pharmacol198928103107doi: 10.1111/j.1365-2125.1989.tb03511.x2775608
- 74MilanovITotevaSGeorgievDAlcohol withdrawal tremorElectromyogr Clin Neurophysiol19963615208654316
- 75WharradHJBirminghamATWilsonCGWilliamsEJRolandJMEffect on finger tremor of withdrawal of long-term treatment with propranolol or atenololBr J Clin Pharmacol198418317324doi: 10.1111/j.1365-2125.1984.tb02470.x6487471
- 76DworkinLAGoldmanRDZivinLSFuchsPCCerebellar toxicity following high-dose cytosine arabinosideJ Clin Oncol19853613616doi: 10.1200/JCO.1985.3.5.6133998779
- 77Lefebre-D’AmourMShahaniBTYoungRRTremor in alcoholic patientsProg Clin Neurophysiol19785160164